HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-transcriptional regulation by interferon-alpha of epsilon-globin production in human erythroleukemia K-562 cells.

Abstract
Treatment of human K-562 erythroleukemia cells with interferon-alpha (IFN-alpha) resulted in a six-fold increase in the production of epsilon-globin, a component of embryonic hemoglobin, but in a two-fold or less augmentation of the production of other globin species. There was no comparable increase in the production of epsilon-globin mRNA following IFN treatment. We did, however, observe a shift in the cytoplasmic location of the epsilon-globin mRNA from the messenger ribonucleoprotein (mRNP) to the polysome fraction after IFN-alpha addition. No such shift was noted in the location of the mRNA for A gamma-globin, the major globin product of K-562 cells, which was always present in the polysome fraction. These results are significant with respect to the mechanisms of cellular regulation and differentiation induced by IFNs.
AuthorsR M Friedman, A Yeh, W Tang
JournalJournal of interferon research (J Interferon Res) Vol. 12 Issue 4 Pg. 311-6 (Aug 1992) ISSN: 0197-8357 [Print] United States
PMID1431310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • DNA Probes
  • DNA, Neoplasm
  • Hemoglobins
  • Interferon-alpha
  • RNA, Messenger
  • RNA, Neoplasm
  • Ribonucleoproteins
  • Globins
Topics
  • Antibodies, Monoclonal
  • Cytosol (metabolism)
  • DNA Probes
  • DNA, Neoplasm (analysis)
  • Globins (biosynthesis, genetics)
  • Hemoglobins (analysis)
  • Humans
  • Interferon-alpha (pharmacology)
  • Leukemia, Erythroblastic, Acute (metabolism)
  • Polyribosomes (metabolism)
  • RNA, Messenger (biosynthesis)
  • RNA, Neoplasm (analysis)
  • Ribonucleoproteins (metabolism)
  • Transcription, Genetic (genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: